Search Results 211-220 of 23020 for Phase

  1. The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis - Mayo Clinic

    Subjects will remain on-study until study completion, which will occur when all primary endpoint events (all-cause mortality or cardiac hospitalizations) have ...

  2. Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer - Mayo Clinic

    Part A: (ADXS11-001 + MEDI4736 Combination Therapy) will determine the safety and tolerability of the combination and to identify a RP2D. Part B: Phase 2 design ...

  3. A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation - Mayo Clinic

    A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation · Overview · Participation eligibility · Participating ...

  4. A Phase 1, Study of BMF-500 in Adults With Acute Leukemia - Mayo Clinic

    A Phase 1, Study of BMF-500 in Adults With Acute Leukemia · Overview · Participation eligibility · Participating Mayo Clinic locations · More information ...

  5. Delayed sleep phase - Doctors and departments - Mayo Clinic

    Learn more on the Center for Sleep Medicine research website. Publications. See a list of publications about delayed sleep phase by Mayo Clinic doctors on ...

  6. A Phase I Study of TAS-102 in Patients with Advanced Solid Tumors with Renal Impairment - Mayo Clinic

    Clinical Trials · A Phase I Study of TAS-102 in Patients with Advanced Solid Tumors with Renal Impairment · More about research at Mayo Clinic · Mayo Clinic Footer.

  7. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

    Background: Sometimes the cancer advanced alveolar soft part sarcoma (ASPS) cannot be helped with surgery or other treatment. The drug atezolizumab unblocks the ...

  8. Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC) - Mayo Clinic

    Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC) · Share · Facebook · Twitter.

  9. Zanzalintinib Versus Everolimus In Participants With Locally Advanced Or Metastatic Neuroendocrine Tumors - Mayo Clinic

    Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases ...

  10. A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...